Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Short-Term Debt: ¥0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603882 Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
79 GF Score
Price ¥27.42
GF Value ¥28.31
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Guangzhou Kingmed Diagnostics Group Co Short-Term Debt?

Guangzhou Kingmed Diagnostics Group Co SHSE:603882 -1.93% 79 Short-Term Debt is ¥0 Mil as of Jun. 2026. GuruFocus rates SHSE:603882 with a GF Score™ of 79/100 and a GF Value™ of ¥28.31 (Fairly Valued). The stock has 7 warning signs investors should review.

Guangzhou Kingmed Diagnostics Group Co's Short-Term Debt for the quarter that ended in Jun. 2026 was ¥0 Mil.

Guangzhou Kingmed Diagnostics Group Co's annual Short-Term Debt increased from Dec. 2023 (¥1 Mil) to Dec. 2024 (¥1 Mil) but then declined from Dec. 2024 (¥1 Mil) to Dec. 2025 (¥0 Mil).

Guangzhou Kingmed Diagnostics Group Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Guangzhou Kingmed Diagnostics Group Co Short-Term Debt Related Terms

Guangzhou Kingmed Diagnostics Group Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co Short-Term Debt Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.00 1.00 0.00

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:603882
79GF Score
Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ¥0 Mil mean?
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a Short-Term Debt of ¥0 Mil as of Jun. 2026.
Is Guangzhou Kingmed Diagnostics Group Co's Short-Term Debt too high?
Guangzhou Kingmed Diagnostics Group Co's current Short-Term Debt is ¥0 Mil. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's Short-Term Debt compare to TMO and DHR?
Guangzhou Kingmed Diagnostics Group Co's Short-Term Debt of ¥0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Guangzhou Kingmed Diagnostics Group Co's current Short-Term Debt is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.31, compared to a current price of ¥27.42 — trading 3.1% below its estimated fair value. The current Short-Term Debt is ¥0 Mil. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current Short-Term Debt is ¥0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be undervalued. The current stock price of ¥27.42 is trading 3.1% below its estimated GF Value™ of ¥28.31. GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.

Key valuation signals for SHSE:603882:

  • Short-Term Debt: ¥0 Mil
  • GF Value™: ¥28.31 vs. price of ¥27.42 (3.1% below fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Kingmed Diagnostics Group Co Business Description

Address International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
79GF Score

Get the complete analysis for SHSE:603882

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.42
Price
¥28.31
GF Value